AS
CLBT icon

Altshuler Shaham’s Cellebrite CLBT Stock Holding History

Altshuler Shaham’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Buy
199
+107
+116% +$1.41K ﹤0.01% 445
2026
Q1 		$1.27K Buy
92
+22
+31% +$332 ﹤0.01% 411
2025
Q4 		$1.26K Buy
70
+42
+150% +$754 ﹤0.01% 385
2025
Q3 		$519 Buy
+28
New +$440 ﹤0.01% 362

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Altshuler Shaham's CLBT Position: Q2 2026 in Review

Altshuler Shaham increased its Cellebrite (CLBT) stake by 116% in Q2 2026, buying an estimated $1.41K and bringing the position to 199 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Altshuler Shaham first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Altshuler Shaham held 199 shares of Cellebrite worth $2.9K as of Q2 2026.
  • Altshuler Shaham bought 107 Cellebrite shares in Q2 2026, an estimated $1.41K.
  • Cellebrite made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #445 holding.
  • Altshuler Shaham first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.